The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus: Paradoxes resolve to cooperation in carcinogenesis in vivo

Carcinogenesis

Volumn 24, Issue 7, 2003, Pages 1209-1218

  Macdiarmid, Jennifer ^a   Stevenson, David ^a   Campbell, Donald H ^a   Wilson, Joanna B ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; LATENT MEMBRANE PROTEIN 1; PROTEIN P14; PROTEIN P16; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BENIGN TUMOR; CARCINOGENESIS; COOPERATION; CROSS BREEDING; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; GENE DELETION; GENE LOCUS; GENE LOSS; GENETIC CODE; GROWTH INHIBITION; GROWTH RATE; HETEROZYGOSITY; IN VIVO STUDY; MALIGNANT TRANSFORMATION; MOUSE; MOUSE STRAIN; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; SKIN CANCER; SKIN CARCINOGENESIS; SKIN PAPILLOMA; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; WILD TYPE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BLOTTING, WESTERN; CARCINOGENS; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; DNA; DNA PRIMERS; EPIDERMIS; EPITHELIAL CELLS; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NASOPHARYNGEAL NEOPLASMS; PAPILLOMA; POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; VIRAL MATRIX PROTEINS;

EID: 0042168998     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg070     Document Type: Article

References (55)

1. Le Roux,F. and Joab,I. (1998) Epstein-Barr virus and nasopharyngeal carcinoma. Epstein-Barr Virus Rep., 5, 53-57.
2. IARC (1997) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, no. 70, Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. IARC, Lyon.
3. Buell,P. (1974) The effect of migration on the risk of nasopharyngeal cancer among Chinese. Cancer Res., 34, 1189-1191.
4. Huang,D.P., Ho,J.H., Saw,D. and Teoh,T.B. (1978) Carcinoma of the nasal and paranasal regions in rats fed Cantonese salted marine fish. IARC Sci. Publ., 20, 315-328.
5. Poirier,S., Ohshima,H., de-The,G., Hubert,A., Bourgade,M.C. and Bartsch,H. (1987) Volatile nitrosamine levels in common foods from Tunisia, south China and Greenland, high-risk areas for nasopharyngeal carcinoma (NPC). Int. J. Cancer, 39, 293-296.
6. Simons,M.J., Wee,G.B., Chan,S.H. and Shanmugaratnam,K. (1975) Probable identification of an HL-A second-locus antigen associated with a high risk of nasopharyngeal carcinoma. Lancet, 1, 142-143.
7. Liebowitz,D. (1994) Nasopharyngeal carcinoma: the Epstein-Barr virus association. Semin. Oncol., 21, 376-381.
8. Lu,S.J., Day,N.E., Degos,L. et al. (1990) Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature, 346, 470-471.
9. Hildesheim,A., Anderson,L.M., Chen,C.J. et al. (1997) CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J. Natl Cancer Inst., 89, 1207-1212.
10. Chen,Y.J., Ko,J.Y., Chen,P.J., Shu,C.H., Hsu,M.T., Tsai,S.F. and Lin,C.H. (1999) Chromosomal aberrations in nasopharyngeal carcinoma analyzed by comparative genomic hybridization. Genes Chromosomes Cancer, 25, 169-175.
11. Lo,K.W., Huang,D.P. and Lau,K.M. (1995) p16 gene alterations in nasopharyngeal carcinoma. Cancer Res., 55, 2039-2043.
12. Lo,K.W., Teo,P.M., Hui,A.B., To,K.F., Tsang,Y.S., Chan,S.Y., Mak,K.F., Lee,J.C. and Huang,D.P. (2000) High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res., 60, 3348-3353.
13. Lo,K.W., Cheung,S.T., Leung,S.F. et al. (1996) Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res., 56, 2721-2725.
14. Huang,D.P., To,K.F. and Lo,K.W. (2002) Molecular pathogenesis of nasopharyngeal carcinoma. Epstein-Barr Virus Rep., 9, 43-54.
15. Brooks,L., Yao,Q.Y., Rickinson,A.B. and Young,L.S. (1992) Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1 and LMP2 transcripts. J. Virol., 66, 2689-2697.
16. Sheen,T.S., Huang,Y.T., Chang,Y.L., Ko,J.Y., Wu,C.S., Yu,Y.C., Tsai,C.H. and Hsu,M.M. (1999) Epstein-Barr virus-encoded latent membrane protein 1 co-expresses with epidermal growth factor receptor in nasopharyngeal carcinoma. Jpn. J. Cancer Res., 90, 1285-1292.
17. Pathmanathan,R., Prasad,U., Sadler,R., Flynn,K. and Raab-Traub,N. (1995) Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N. Engl. J. Med., 333, 693-698.
18. Wang,D., Liebowitz,D. and Kieff,E. (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell, 43, 831-840.
19. Baichwal,V.R. and Sugden,B. (1988) Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene, 2, 461-467.
20. Fåhraeus,R., Rymo,L., Rhim,J.S. and Klein,G. (1990) Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature, 345, 447-449.
21. Dawson,C.W., Rickinson,A.B. and Young,L.S. (1990) Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature, 344, 777-780.
22. Kaye,K.M., Izumi,K.M. and Kieff,E. (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl Acad. Sci. USA, 90, 9150-9154.
23. Wilson,J.B., Weinberg,W., Johnson,R., Yuspa,S. and Levine,A.J. (1990) Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell, 61, 1315-1327.
24. Curran,J.A., Laverty,F.S., Campbell,D., Macdiarmid,J. and Wilson,J.B. (2001) Epstein-Barr virus encoded latent membrane protein-1 induces epithelial cell proliferation and sensitizes transgenic mice to chemical carcinogenesis. Cancer Res., 61, 6730-6738.
25. Miller,W.E., Earp,H.S. and Raab-Traub,N. (1995) The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J. Virol., 69, 4390-4398.
26. Zheng,X., Hu,L., Chen,F. and Christensson,B. (1994) Expression of Ki67 antigen, epidermal growth factor receptor and Epstein-Barr virus-encoded latent membrane protein (LMP1) in nasopharyngeal carcinoma. Eur. J. Cancer B Oral Oncol., 30B, 290-295.
27. Eliopoulos,A.G., Stack,M., Dawson,C.W., Kaye,K.M., Hodgkin,L., Sihota,S., Rowe,M. and Young,L.S. (1997) Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors. Oncogene, 14, 2899-2916.
28. Eliopoulos,A.G., Gallagher,N.J., Blake,S.M., Dawson,C.W. and Young,L.S. (1999) Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J. Biol. Chem., 274, 16085-16096.
29. Yoshizaki,T., Sato,H., Furukawa,M. and Pagano,J.S. (1998) The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc. Natl Acad. Sci. USA, 95, 3621-3626.
30. Horikawa,T., Yoshizaki,T., Sheen,T.S., Lee,S.Y. and Furukawa,M. (2000) Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer, 89, 715-723.
31. Eliopoulos,A.G., Dawson,C.W., Mosialos,G. et al. (1996) CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene, 13, 2243-2254.
32. Hammerschmidt,W., Sugden,B. and Baichwal,V.R. (1989) The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J. Virol., 63, 2469-2475.
33. Cuomo,L., Ramquist,T., Trivedi,P., Wang,F., Klein,G. and Masucci,M.G. (1992) Expression of the Epstein-Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability and tumorigenicity of an EBV-negative Burkitt lymphoma line. Int. J. Cancer, 51, 949-955.
34. Floettmann,J.E., Ward,K., Rickinson,A.B. and Rowe,M. (1996) Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology, 223, 29-40.
35. Kaykas,A. and Sugden,B. (2000) The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation. Oncogene, 19, 1400-1410.
36. Liu,Y., Wang,X., Lo,A.K., Wong,Y.C., Cheung,A.L. and Tsao,S.W. (2002) Latent membrane protein-1 of Epstein-Barr virus inhibits cell growth and induces sensitivity to cisplatin in nasopharyngeal carcinoma cells. J. Med. Virol., 66, 63-69.
37. Akhurst,R.J. and Balmain,A. (1999) Genetic events and the role of TGFβ in epithelial tumour progression. J. Pathol., 187, 82-90.
38. Berenblum,I. (1978) Established principles and unresolved problems in carcinogenesis. J. Natl Cancer Inst., 60, 723-726.
39. Linardopoulos,S., Street,A.J., Quelle,D.E., Parry,D., Peters,G., Sherr,C.J. and Balmain,A. (1995) Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors. Cancer Res., 55, 5168-5172.
40. Sherr,C.J. (2001) The INK4a/ARF network in tumour suppression. Nature Rev. Mol. Cell. Biol., 2, 731-737.
41. Serrano,M., Lee,H., Chin,L., Cordon-Cardo,C., Beach,D. and DePinho,R.A. (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell, 85, 27-37.
42. Wilson,J.B. and Drotar,M.E. (2001) Considerations in generating transgenic mice: DNA, RNA and protein extractions from tissues-rapid and effective blotting. In Wilson,J.B. and May,G.H.W. (eds), Methods in Molecular Biology, Vol. 174, Epstein-Barr Virus Protocols. Humana Press, Totowa, NJ, pp. 361-377.
43. Curran,J. (2001) Topical chemical carcinogen treatment in mice. In Wilson,J.B. and May,G.H.W. (eds), Methods in Molecular Biology, Vol. 174, Epstein-Barr Virus Protocols. Humana Press, Totowa, NJ, pp. 391-399.
44. Serrano,M. (2000) The INK4a/ARF locus in murine tumorigenesis. Carcinogenesis, 21, 865-869.
45. Yang,X., He,Z., Xin,B. and Cao,L. (2000) LMP1 of Epstein-Barr virus suppresses cellular senescence associated with the inhibition of p16INK4a expression. Oncogene, 19, 2002-2013.
46. Macleod,K. (1999) pRb and E2f-1 in mouse development and tumorigenesis. Curr. Opin. Genet. Dev., 9, 31-39.
47. Rossiter,H., Beissert,S., Mayer,C., Schon,M.P., Wienrich,B.G., Tschachler,E. and Kupper,T.S. (2001) Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis. Cancer Res., 61, 3619-3626.
48. Kemp,C.J., Donehower,L.A., Bradley,A. and Balmain,A. (1993) Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell, 74, 813-822.
49. Greenhalgh,D.A., Wang,X.J., Donehower,L.A. and Roop,D.R. (1996) Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor-α. Cancer Res., 56, 4413-4423.
50. Nicholson,L.J., Hopwood,P., Johannessen,I., Salisbury,J.R., Codd,J., Thorley-Lawson,D. and Crawford,D.H. (1997) Epstein-Barr virus latent membrane protein does not inhibit differentiation and induces tumorigenicity of human epithelial cells. Oncogene, 15, 275-283.
51. Vos,M.D., Ellis,C.A., Bell,A., Birrer,M.J. and Clark,G.J. (2000) Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J. Biol. Chem., 275, 35669-35672.
52. Zhang,S.L., DuBois,W., Ramsay,E.S., Bliskovski,V., Morse,H.C.,III, Taddesse-Heath,L., Vass,W.C., DePinho,R.A. and Mock,B.A. (2001) Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility. Mol. Cell. Biol., 21, 310-318.
53. Rizos,H., Darmanian,A.P., Holland,E.A., Mann,G.J. and Kefford,R.F. (2001) Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF. J. Biol. Chem., 276, 41424-41434.
54. Mantelli,M., Barile,M., Ciotti,P. et al. (2002) High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families. Am. J. Med. Genet., 107, 214-221.
55. Jefferies,S., Edwards,S.M., Hamoudi,R.A., A'Hern,R., Foulkes,W., Goldgar,D. and Eeles,R. (2001) No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours. Br. J. Cancer, 85, 1383-1386.